Difference between revisions of "Team:TCU Taiwan/Project/Experimental"
Line 75: | Line 75: | ||
<img src="https://static.igem.org/mediawiki/2015/3/3c/TCU_Taiwan_Signal_Peptide_2.jpeg"> | <img src="https://static.igem.org/mediawiki/2015/3/3c/TCU_Taiwan_Signal_Peptide_2.jpeg"> | ||
<br><br> | <br><br> | ||
− | <font size="5"></font> | + | <font size="5">Fig.2 Epinecidin-1 fusion peptide design model</font> |
</p> | </p> | ||
</div> | </div> |
Revision as of 16:27, 18 September 2015
Signal Peptide |
To increase efficiency in isolating our AMPs, we introduced a signal peptide upstream of the N-terminal of antimicrobial peptides to facilitate peptide production. This signal peptide is obtained from chitinase C of S.lividans (MGFRHKAAALAATLALPLAGLVGLASPAQA). After translation process, this signal peptide will lead AMPs to the secretion system of E. coli. When the premature peptides enter the periplasmic space, peptidase will identify the cleavage site Ala-Gln-Ala and cut at the double Ala at the signal and mature peptide linkage site. This separates the signal peptide from the AMP. To verify the E. coli secretion of AMPs to the LB culture medium, we attached an Ala at the N-terminal of AMPs.[1,2]
|
Fig.1 Signiferin fusion peptide design model
Fig.2 Epinecidin-1 fusion peptide design model
Contact us tcutaiwan@gmail.com No.701, Sec. 3, Zhongyang Rd. Hualien 97004, Taiwan |